Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Media & Investors
Transparency is important to us. Find important information about Kuros Biosciences here – from our corporate documents to our current share price.
Press releases
Click each card below for our latest press releases.
For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.
23 Nov 2022
Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH
26 Oct 2022
Adhoc Press Release
Kuros reports 73% increase in MagnetOs sales in first nine months of 2022
19 Oct 2022
Kuros Biosciences awarded 2022 Spine Technology Award for MagnetOs Flex Matrix by Orthopedics This Week
Reports, Corporate Governance & Meetings
Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.
Analysts
Laura Pfeifer-Rossi
Octavian AG
Please use the button below to view and download Analyst reports
Calendar
| Date | Event |
|---|---|
| Mar 14, 2023 | Kuros will publish its Annual Report for 2022 |
| May 08, 2023 | Kuros will organize its Annual General Meeting 2023 |
| Aug 09, 2023 | Kuros will publish its Half Year Report for H1 2023 |
If you have any questions, please let us know.